Prevalence, Incidence and Factors Associated with Diabetic Foot in People with Type 2 Diabetes: Systematic Review with Meta-Analysis
- Autores: de Jesus Nascimento de Aquino M.1, de Souza A.C.1, Borges J.W.2, da Silva Negreiros F.1, de Sousa Gonçalves M.3, Martins P.M.2, Moreira T.M.4
-
Afiliações:
- Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, Rodolfo Teófilo, Fortaleza, Ceará, 60430-372, Brazil
- Department of Nursing, Federal University of Piauí, Teresina, Brazil
- Department of Nursing, Centro Universitário UNINTA, Sobral, Brazil
- Clinical Care in Nursing and Health Gradutate Program, Universidade Estadual do Ceará, Fortaleza, Brazil
- Edição: Volume 20, Nº 1 (2024)
- Seção: Medicine
- URL: https://snv63.ru/1573-3998/article/view/642947
- DOI: https://doi.org/10.2174/1573399819666230407093450
- ID: 642947
Citar
Texto integral
Resumo
Background:Diabetic Foot is a severe chronic complication of diabetes and an important factor in the morbidity of diabetic people, resulting in high health costs and increased risk of death.
Objective:To analyze the incidence, prevalence, and risk factors associated with diabetic foot in people with type 2 Diabetes Mellitus.
Method:Systematic literature review. Searches in MedLine via PubMed, LILACS, Web of Science, Scopus CINAHL, and Cochrane Library databases were performed. Inclusion of 52 studies. The R program, Metan packages, was used to calculate the meta-analysis. Given the heterogeneity of studies, the random effect was used to calculate the meta-analysis of risk factors.
Results:The meta-analysis showed that the prevalence of diabetic foot was 14% in a hospital setting and 5% in a community setting. The overall prevalence and incidence were 9% and 4%, respectively. Significant risk factors included time of DM (odds ratio [OR] =1.46, confidence interval [CI], 0.36-2.57, P = 0.009), smoking (OR = 1.46, CI, 1.16 -1.85, P< .001), glycated hemoglobin (OR = 0.96, CI, 0.50; 1.42, P< .001), peripheral arterial disease (OR = 3.38, CI, 2.07; 5.53, P < .001) and peripheral neuropathy (OR = 5.88, CI, 2.39-14.45, P<.001).
Conclusion:Multidisciplinary monitoring, educational strategies, periodic foot examination for alterations, and early identification of risk factors are essential to prevent ulceration and reduce the disease burden.
Palavras-chave
Sobre autores
Maria de Jesus Nascimento de Aquino
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Email: info@benthamscience.net
Ana de Souza
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Autor responsável pela correspondência
Email: info@benthamscience.net
José Borges
Department of Nursing, Federal University of Piauí, Teresina, Brazil
Email: info@benthamscience.net
Francisca da Silva Negreiros
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Email: info@benthamscience.net
Marilia de Sousa Gonçalves
Department of Nursing, Centro Universitário UNINTA, Sobral, Brazil
Email: info@benthamscience.net
Polyanna Martins
Department of Nursing, Federal University of Piauí, Teresina, Brazil
Email: info@benthamscience.net
Thereza Moreira
Clinical Care in Nursing and Health GradutateProgram, Universidade Estadual do Ceará, Fortaleza, Brazil
Email: info@benthamscience.net
Arquivos suplementares
